Latest Biotech News

Researchers reported that simultaneously modulating STING, TGF‑β, and PD‑L1 pathways dramatically enhances antitumor immunity through activation of the CXCL16–CXCR6 axis. The triple-targeting...

A translational study showed that the Parkinson’s-linked LRRK2 R1627P mutation amplifies gut inflammation and promotes α‑synuclein aggregation in rat models. Investigators reported increases in...

Scientists at the Centre for Cellular and Molecular Biology (CCMB) reported that metabolic programs in fungi underpin invasive behavior and determine responsiveness to antifungal therapy. The team...

Las Vegas police and federal agents arrested an Israeli national, Ori Salomon (aka Ori Solomon), after a residential property used as an alleged biological laboratory reportedly left several...

Telehealth company Hims & Hers announced it would stop offering a compounded version of Novo Nordisk’s Wegovy following legal threats from federal regulators and pressure from Novo Nordisk. The...

OpenEvidence reached a $12 billion valuation as investor demand climbed behind its clinician‑first AI medical search tool, which the company says is used regularly by more than 430,000 clinicians....

Hims & Hers abruptly stopped offering a compounded version of Novo Nordisk’s Wegovy after escalating legal pressure from U.S. federal regulators and threats of enforcement action. The company...

A Priovant Therapeutics proof‑of‑concept study showed brepocitinib, a dual JAK1/TYK2 inhibitor licensed from Pfizer, met its goals in cutaneous sarcoidosis — a rare inflammatory skin disorder with...

Las Vegas police arrested an Israeli national after discovering a residential property configured as an apparent biological laboratory with freezers, a biosafety hood, centrifuge and more than...

OpenEvidence’s reported $12 billion valuation reflects rapid clinical adoption of its doctor‑first AI medical search tool, which the company says is used regularly by more than 430,000 clinicians...

Researchers publishing in Nature Communications reported that a bacteriophage‑antibiotic combination successfully cleared refractory peritoneal dialysis‑related peritonitis caused by Klebsiella...

A 2026 Nature Communications paper identified the inflammasome‑associated protein ASC as a molecular link between innate immune signaling and mitochondrial metabolism in pancreatic cancer cells....

A team publishing in Nature Communications unveiled a 3D gut‑brain‑vascular platform that models bidirectional communication among gut, neural and vascular tissues. The system recapitulates...

Researchers report that the LRRK2 R1627P mutation intensifies gut inflammation and accelerates α‑synuclein aggregation in rat models, linking a genetic Parkinson’s risk factor to early gut...

A Clinical Toxicology study from King’s College London found that fatalities involving nitazene synthetic opioids may be undercounted by as much as one‑third, owing to limitations in toxicology...

BioSpace’s layoff tracker reported workforce reductions at major contract research and laboratory services providers including Charles River and Thermo Fisher Scientific alongside site closures....

Hims & Hers stopped offering a compounded version of Novo Nordisk’s Wegovy after escalating federal pressure and legal threats. The company said it “decided to stop offering access” to the...

Priovant Therapeutics, a Roivant Sciences subsidiary, reported that brepocitinib—a dual JAK1/TYK2 inhibitor licensed from Pfizer—met endpoints in a proof‑of‑concept study in cutaneous sarcoidosis....

Sanofi disclosed detailed results from a failed Phase 3 trial of the BTK inhibitor tolebrutinib in primary progressive multiple sclerosis (PPMS). The company’s presentation at ACTRIMS highlighted...

Researchers reported in Nature Communications that combining bacteriophage therapy with antibiotics eradicated refractory Klebsiella pneumoniae peritonitis in a preclinical peritoneal dialysis...